Megfine 160mg Tablet

About

Megfine 160mg Tablet is a synthetic progestin primarily indicated for the effective management of anorexia, cachexia, or unexplained significant weight loss in patients suffering from advanced cancer or acquired immunodeficiency syndrome (AIDS). Its mechanism of action for stimulating appetite and promoting weight gain is believed to involve complex interactions with various metabolic pathways and the regulation of inflammatory cytokines, ultimately leading to increased caloric intake and a positive impact on body weight. Additionally, it exhibits notable antineoplastic activity, making it a valuable agent in the palliative treatment of specific hormone-sensitive malignancies. This particular dosage is specifically formulated for its potent anti-cachectic effects, aiming to improve nutritional status and enhance the overall quality of life for patients facing chronic debilitating illnesses.

Uses

• Treatment of anorexia in AIDS patients
• Management of cachexia in cancer patients
• Palliative treatment of advanced breast cancer
• Palliative treatment of advanced endometrial cancer

Directions For Use

Take one tablet orally once daily, or as prescribed by your healthcare provider.

Benefits

• Increases appetite and food intake
• Promotes healthy weight gain
• Improves nutritional status
• Enhances quality of life in chronic illness
• May reduce fatigue associated with weight loss
• Offers palliative care benefits

Side Effects

• Weight gain
• Nausea
• Diarrhea
• Flatulence
• Rash
• Insomnia
• Hot flashes
• Headache
• Edema
• Thromboembolic events (rare)
• Adrenal suppression (long-term, high dose)
• Breakthrough bleeding (in women)

Safety Measures

• Alcohol - Moderate alcohol consumption is generally safe, but excessive intake may exacerbate some side effects like nausea or dizziness.
• Pregnancy - Contraindicated during pregnancy due to potential harm to the fetus; use effective contraception.
• Breastfeeding - Not recommended during breastfeeding as it may be excreted in milk and affect the infant.
• Liver - Use with caution in patients with liver impairment; monitor liver function periodically.
• Kidney - Generally safe for use in patients with kidney conditions; no dose adjustment typically required.
• Lung - No specific contraindications related to lung conditions, but monitor for thromboembolic events, especially in predisposed patients.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.